Log in or Sign up for Free to view tailored content for your specialty!
Bipolar Disorder News
Alzamend Neuro submits IND for bipolar disorder therapeutic
A clinical-stage biopharmaceutical company has announced the submission of an investigational new drug application to the FDA based upon results of a phase 2a clinical study of a novel lithium delivery system, AL001, for bipolar disorder.
Adjunctive antidepressants little better than placebo in stemming mood relapse in bipolar 1
Continuing adjunctive antidepressant therapy for 52 weeks after depressive episode remission in patients with bipolar 1 disorder did not significantly delay further mood episodes vs. stopping treatment after 8 weeks, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
AbbVie committed to extending clinical value of its therapeutics
BOSTON — With a multitude of products spanning neuroscience and psychiatry, executives at AbbVie say they are committed to learning the full clinical value of all of the company’s products for the benefit of patients.
Symptom dimensions within bipolar disorder may have distinct causes
Symptom dimensions within bipolar disorder may have distinct causes, supporting the hypothesis that genetic heterogeneity underpins clinical heterogeneity, according to a study published in The Lancet Psychiatry.
VIDEO: Diagnosis, treatment of late-life mood and anxiety disorders require close attention
SAN FRANCISCO — Diagnosis and treatment of mood and anxiety disorders experienced late in life require detailed medical and psychological history, according to a presenter at the American Psychiatric Association annual meeting. .
VIDEO: Collaboration key to provide behavioral health services for homeless population
SAN FRANCISCO — Collaboration and communication between mental and physical health services is crucial to overcome logistics of providing proper care for homeless individuals in a large city, Carine Nzodom, MD, says in a Healio video.
Telepsychiatry effective for bipolar disorder, more research required
MIAMI BEACH, Fla. — Telepsychiatry may be a safe and effective tool to treat bipolar disorder in adolescents and adults, but deeper research is needed, according to a poster at the American Society of Psychopharmacology annual meeting.
Journal club effective for expanding body of knowledge on ketamine, other psych drugs
MIAMI BEACH, Fla. — Creation of an interactive online journal club was effective in expanding the body of knowledge for ketamine and related compounds prescribed for psychiatric disorders, according to a presenter.
VIDEO: Evidence supports bipolar disorder diagnosis in children
SAN FRANCISCO — Emerging research supports bipolar disorder as a valid diagnosis in children, according to a speaker at the American Psychiatric Association.
Perceived impact of tardive dyskinesia differs among patients, health care professionals
CHICAGO — Patients with tardive dyskinesia reported greater impact on quality of life than health care providers, according to a poster at the International Association of Parkinsonism and Related Disorders World Congress.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read